VeriMomphaseolus vulgaris phytoplacenta extract은 임신 중 안전한가요?
No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer-reviewed evidence of teratogenicity or reproductive toxicity for Phaseolus vulgaris phytoplacenta extract were identified in available databases. Botanical extracts of this type are typically high‑molecular-weight mixtures unlikely to be systemically bioactive when applied topically (sources: ECHA Annex VI, CosIng, PubMed literature search absent specific reproductive studies).
성분
phaseolus vulgaris phytoplacenta extract
알려진 위험 없음100
/100
0
Related ingredients
Frequently asked questions
- phaseolus vulgaris phytoplacenta extract은 임신 중 안전한가요?
- No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer-reviewed evidence of teratogenicity or reproductive toxicity for Phaseolus vulgaris phytoplacenta extract were identified in available databases. Botanical extracts of this type are typically high‑molecular-weight mixtures unlikely to be systemically bioactive when applied topically (sources: ECHA Annex VI, CosIng, PubMed literature search absent specific reproductive studies).
- phaseolus vulgaris phytoplacenta extract은 모유 수유 중 안전한가요?
- No data indicating mammary transfer or lactation-related hazards; no harmonised or authoritative reviews raising concerns. Given lack of evidence for systemic reproductive toxicity and probable limited dermal absorption for a plant placental extract, risk via breastmilk is not indicated (sources: CosIng, PubMed, ECHA Annex VI absence).
- phaseolus vulgaris phytoplacenta extract은 아기 피부에 안전한가요?
- Hazard (h) and mechanism (m): no infant-specific reproductive/toxicology evidence found. Exposure (e) increased to 1 because infant skin has higher surface-area-to-weight and a less mature barrier; although the extract is likely high‑molecular-weight and not readily absorbed, neonatal/infant percutaneous absorption can be greater, so low but measurable exposure is plausible for topical use (sources: CosIng, general dermal absorption principles).
- VeriMom은 phaseolus vulgaris phytoplacenta extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 phaseolus vulgaris phytoplacenta extract을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 phaseolus vulgaris phytoplacenta extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.